Intrinsic value of Iterum Therapeutics plc (ITRM)
Live fair value data for Iterum Therapeutics plc (ITRM) is currently unavailable. Please check again shortly.
Current Price: $206.00
Valuation: Undervalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Iterum Therapeutics plc (ITRM) undervalued or overvalued?
Based on the current model output, Iterum Therapeutics plc appears to be undervalued with a upside of 9.00%.
Fair value vs market price — Iterum Therapeutics plc (ITRM)
Unlock premium access to view the live fair value comparison against current market price for ITRM.
Frequently Asked Questions - ITRM
How is ITRM intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for ITRM.
Is ITRM undervalued or overvalued right now?
ITRM is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for ITRM: open their intrinsic value pages.